© 2022 MJH Life Sciences™ and HCPLive - Clinical news for connected physicians. All rights reserved.
June 21, 2022
Raj J. Chovatiya, MD, PhD; Elizabeth A. Swanson, MD; Tina Capps; and Taylor Capps assess barriers in finding and obtaining atopic dermatitis treatments.
Elizabeth A. Swanson, MD, discusses the safety and efficacy of dupilumab in treating moderate to severe atopic dermatitis, and Taylor Capps shares her journey with dupilumab from insurance approvals through receiving treatment.
June 14, 2022
Raj J. Chovatiya, MD, PhD, reviews goals of therapy for patients with atopic dermatitis and comments on the use of various topical therapies and systemic agents for disease management.
Korey Capozza, MPH, examines the role of multidisciplinary care for patients with atopic dermatitis, and Taylor Capps shares the impact of atopic dermatitis on mental health.
Joshua J. Joseph, MD: Managing CV Risk Factors in Patients with Type 2 Diabetes
Antirituximab Antibodies Detected in Patients with Pemphigus
Investigators Recommend 2 PROMs for Use in Acne Vulgaris